New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis (Q35691924)

9 August 2017

0 references

1 reference

title

New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis (English)

1 reference

9 August 2017

0 references

1 reference

Robert Balshaw

3

0 references

author name string

Olaf Heisel

series ordinal

1

1 reference

9 August 2017

Rochelle Heisel

series ordinal

2

1 reference

9 August 2017

Paul Keown

series ordinal

4

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 April 2004

1 reference

American Journal of Transplantation

9 August 2017

1 reference

9 August 2017

4

1 reference

9 August 2017

583-595

1 reference

9 August 2017

4

1 reference

A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years

9 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00372.X

A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00372.X

Cyclosporine and tacrolimus (FK506): a comparison of efficacy and safety profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00372.X

Incidence and Cost of New Onset Diabetes Mellitus Among U.S. Wait-Listed and Transplanted Renal Allograft Recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00372.X

Diabetes mellitus after renal transplantation: as deleterious as non-transplant-associated diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00372.X

A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00372.X

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00372.X

A large, multicentre trial to compare the efficacy and safety of tacrolimus with cyclosporine microemulsion following renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00372.X

Activity level and balance in subjects with mild Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00372.X

Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. FK506 Kidney Transplant Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00372.X

Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00372.X

One-year follow-up of an open-label trial of FK506 for primary kidney transplantation. A report of the U.S. Multicenter FK506 Kidney Transplant Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00372.X

Predicting the occurrence of diabetes mellitus in recipients of heart transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00372.X

Diabetes mellitus and islet cell specific autoimmunity as adverse effects of immunsuppressive therapy by FK506/tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00372.X

Prednisone withdrawal 14 days after liver transplantation with mycophenolate: a prospective trial of cyclosporine and tacrolimus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00372.X

Tacrolimus or cyclosporine for immunosuppression after cardiac transplantation: which treatment reveals more side effects during long-term follow-up?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00372.X

Diabetes mellitus after kidney transplantation in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00372.X

Tacrolimus versus cyclosporine in primary simultaneous pancreas-kidney transplantation: preliminary results at 1 year of a large multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00372.X

Tacrolimus/mycophenolate mofetil vs cyclosporine A/Azathioprine after simultaneous pancreas and kidney transplantation: five-year results of a randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00372.X

Treatment of tacrolimus-related adverse effects by conversion to cyclosporine in liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00372.X

Posttransplant diabetes mellitus in kidney allograft recipients: incidence, risk factors, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00372.X

High incidence of post-transplant diabetes mellitus in Kuwait

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00372.X

Diabetogenic effect of tacrolimus in South African patients undergoing kidney transplantation1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00372.X

Single-center experience with tacrolimus versus cyclosporine-Neoral in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00372.X

Post-transplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent years

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00372.X

Tapering off prednisolone and cyclosporin the first year after renal transplantation: the effect on glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00372.X

Posttransplantation diabetes mellitus in FK-506-treated renal transplant recipients: analysis of incidence and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00372.X

beta-Cell dysfunction rather than insulin resistance is the main contributing factor for the development of postrenal transplantation diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00372.X

Efficacy of tacrolimus in primary kidney transplant patients: multicenter, open-label prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00372.X

Tacrolimus is highly effective in both dual and triple therapy regimens following renal transplantation. Spanish and Italian Tacrolimus Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00372.X

A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone/mycophenolate mofetil in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00372.X

Post-liver transplantation diabetes mellitus: an association with hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00372.X

Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression - 5 year results of a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00372.X

Steroid elimination 24 hours after liver transplantation using daclizumab, tacrolimus, and mycophenolate mofetil

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00372.X

Liver transplantation under tacrolimus in infants, children, adults, and seniors: long-term results, survival, and adverse events in 1000 consecutive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00372.X

Efficacy and safety of oral low-dose tacrolimus treatment in liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00372.X

Influence of diabetes mellitus on patient and graft survival in recipients of kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00372.X

10.1046/J.1600-6143.2003.00372.X

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference